FDA Releases Early Safety Data Linking Prilosec And Nexium To Cardiac Problems
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is reviewing safety data on Prilosec and Nexium but is not recommending any changes in prescribing practices.
You may also be interested in...
FDA Finds Statins Not Linked To ALS; When Can A False Alarm Be Turned Off?
FDA's determination that statins do not increase the incidence of amyotrophic lateral sclerosis suggests that agency will continue to rely on data from placebo controlled trials to address concerns raised in post-marketing reports
FDA Finds Statins Not Linked To ALS; When Can A False Alarm Be Turned Off?
FDA's determination that statins do not increase the incidence of amyotrophic lateral sclerosis suggests that agency will continue to rely on data from placebo controlled trials to address concerns raised in post-marketing reports
Prilosec Approved For GERD In Infants
Approval comes weeks after Nexium gained clearance in patients 1 to 11.